On Tuesday October 15, JDRF and PureTech announced the launch of T1D Innovations, an exciting new fund that aims to supply crucial funding for the development of type 1...
Research
The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.
41 readers recommended
How you can help to prevent type 1 diabetes…
26 readers recommended
The evolving field of type 1 diabetes and how research should improve to get closer to finding a cure.
50 readers recommended
Can more type 2 therapies be used for type 1 diabetes?
25 readers recommended
Part 1 of our interview with the Helmsley Charitable Trust’s David Panzirer and T1D Exchange's Dana Ball.
31 readers recommended
We sit down with new JDRF CEO Derek Rapp for his first interview as CEO – find out what he's excited about for JDRF's future!
26 readers recommended
Twitter Summary: ViaCyte seeks approval from FDA for first human studies of novel encapsulation stem-cell therapy for #t1D On July 17, ViaCyte filed applications with...
38 readers recommended
Twitter summary: Using a #T2D therapy for #T1D, Lexicon & JDRF partner up for phase 2 trial of SGLT-2/SGLT-1 dual inhibitor drug On July 9, Lexicon announced a...
48 readers recommended
The Future of Type 1 Diabetes – what challenges and promises lie ahead? Part two of our interview with David Panzirer and Dana Ball.
33 readers recommended
What's in store for the Bionic Pancreas? diaTribe visits the Camp Joslin clinical trial in 6-11 year olds for an insider look.
35 readers recommended
How are the bacteria in our gut related to type 2 diabetes and obesity? The fascinating research.
30 readers recommended
Twitter summary: NIH commits $20 million for outpatient artificial pancreas studies for potential FDA submission – a big step that speaks volumes On July 21, the NIH...
24 readers recommended
On May 7, the results of the SEARCH for Diabetes in Youth study published in JAMA found a 21% increase in type 1 diabetes and 31% rise in type 2 diabetes in children...
26 readers recommended
Twitter summary: Due to company misconduct by Andromeda, biotech co. Hyperion terminates development of immune intervention therapy for #T1D On September 8, Hyperion...
30 readers recommended
On June 5, Xeris Pharmaceuticals announced that the first patient had been dosed in its phase 2 clinical trial , which is testing “mini-dose” glucagon for the treatment...
28 readers recommended
Twitter Summary: @DpT1D of the #helmsleytrust talks about need 4 philanthropic support in #T1D in inspiring Wired op-ed David Panzirer , a trustee of the Helmsley...
38 readers recommended
Debates in type 1 diabetes – what is the future of technology and what is a “cure"? Part three of our interview with David Panzirer and Dana Ball.
20 readers recommended
On September 24, JAMA published a paper on long-term trends in the number of people with diabetes in the United States from 1980 to 2012. The results showed a leveling-...
68 readers recommended
Advances for type 2 diabetes at The American Diabetes Association 74th Scientific Sessions
24 readers recommended
Twitter summary: A new technology from Stanford has potential for easier, more accurate, & cheaper diagnosis for #t1d A team of Stanford University researchers, with...